ALXO
Price
$1.22
Change
+$0.14 (+12.96%)
Updated
Sep 5 closing price
Capitalization
65.33M
60 days until earnings call
IPA
Price
$2.07
Change
+$0.14 (+7.25%)
Updated
Sep 3 closing price
Capitalization
91.85M
Interact to see
Advertisement

ALXO vs IPA

Header iconALXO vs IPA Comparison
Open Charts ALXO vs IPABanner chart's image
ALX Oncology Holdings
Price$1.22
Change+$0.14 (+12.96%)
Volume$827.91K
Capitalization65.33M
ImmunoPrecise Antibodies
Price$2.07
Change+$0.14 (+7.25%)
Volume$2.05M
Capitalization91.85M
ALXO vs IPA Comparison Chart in %
Loading...
ALXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALXO vs. IPA commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALXO is a Buy and IPA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (ALXO: $1.22 vs. IPA: $0.00)
Brand notoriety: ALXO and IPA are both not notable
Both companies represent the Biotechnology industry
Market capitalization -- ALXO: $65.33M vs. IPA: $91.85M
ALXO [@Biotechnology] is valued at $65.33M. IPA’s [@Biotechnology] market capitalization is $91.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALXO’s FA Score shows that 0 FA rating(s) are green whileIPA’s FA Score has 1 green FA rating(s).

  • ALXO’s FA Score: 0 green, 5 red.
  • IPA’s FA Score: 1 green, 4 red.
According to our system of comparison, IPA is a better buy in the long-term than ALXO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALXO’s TA Score shows that 3 TA indicator(s) are bullish.

  • ALXO’s TA Score: 3 bullish, 4 bearish.

Price Growth

ALXO (@Biotechnology) experienced а +4.27% price change this week, while IPA (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

ALXO is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALXOIPAALXO / IPA
Capitalization65.3MN/A-
EBITDA-114.05MN/A-
Gain YTD-26.946N/A-
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash79.3MN/A-
Total Debt10MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ALXO
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ALXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EZPZ30.020.44
+1.50%
Franklin Crypto Index ETF
BRTR50.960.23
+0.44%
iShares Total Return Active ETF
JPIB48.870.19
+0.39%
JPMorgan International Bond Opps ETF
AAPR27.73N/A
+0.01%
Innovator Eq Dfnd Prot ETF 2 YrToApl2026
SMDD12.98-0.16
-1.22%
ProShares UltraPro Short MidCap400

ALXO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALXO has been loosely correlated with MDGL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALXO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALXO
1D Price
Change %
ALXO100%
+12.96%
MDGL - ALXO
56%
Loosely correlated
+0.39%
AXON - ALXO
45%
Loosely correlated
-0.24%
AMRN - ALXO
43%
Loosely correlated
+2.00%
ALNY - ALXO
39%
Loosely correlated
-0.34%
VERA - ALXO
36%
Loosely correlated
+10.46%
More